Brett Charlton - Concepedia

Author

Brett Charlton

Pharmaxis (Australia)

Also Known As

B. T. Charlton, BRETT CHARLTON, Brett Charlton, Sandra D Anderson

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Pharmaxis (Australia)Australian National University Walter and Eliza Hall Institute of Medical Research The Royal Melbourne Hospital Stanford University

About

Brett Charlton is an author at Pharmaxis (Australia) specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.2K
2	Allergy	6	6	404
3	Cell Biology	3	3	203
4	Social Sciences	2	2	144
5	Allergy Medicine	1	1	15

Brett Charlton

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline John D. Brannan, Sandra D. Anderson, Clare Perry, Respiratory Research	2005	217
Prevention of diabetes in non-obese diabetic I-Ak transgenic mice Robyn M. Slattery, Lars Kjer‐Nielsen, Janette Allison, Nature ObesityMetabolic SyndromeDiabetesImmunologyDiabetes Mellitus	1990	200
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial Diana Bilton, Gregory Tino, Alan F. Barker, Thorax	2014	166
Administration of Silica Particles or Anti-Lyt2 Antibody Prevents β-Cell Destruction in NOD Mice Given Cyclophosphamide Brett Charlton, Angela Bacelj, T E Mandel Diabetes	1988	154
Inhaled Mannitol Improves Lung Function in Cystic Fibrosis Anna Jaques, Evangelia Daviskas, James A. Turton, CHEST Journal Inflammatory Lung DiseaseAllergyPulmonary PhysiologyPulmonary PharmacologyPulmonary Fibrosis	2008	150
Cyclophosphamide-Induced Diabetes in NOD/WEHI Mice: Evidence for Suppression in Spontaneous Autoimmune Diabetes Mellitus Brett Charlton, Angela Bacelj, Robyn M. Slattery, Diabetes	1989	121
Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis Moira L. Aitken, G. Bellon, K. De Boeck, American Journal of Respiratory and Critical Care Medicine	2011	121
Beta cell MHC class I is a late requirement for diabetes Emma E. Hamilton‐Williams, Stephanie Palmer, Brett Charlton, Proceedings of the National Academy of Sciences Mhc ClassT-regulatory CellImmunologyImmune RegulationPathology	2003	115
Phase 3 Randomized Study of the Efficacy and Safety of Inhaled Dry Powder Mannitol for the Symptomatic Treatment of Non-Cystic Fibrosis Bronchiectasis Diana Bilton, Evangelia Daviskas, Sandra D. Anderson, CHEST Journal AsthmaNon-cystic Fibrosis BronchiectasisPulmonary CareRandomized StudyPulmonary Fibrosis	2013	114
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer Jessica L. Chitty, Michelle Yam, Lara Perryman, Nature Cancer	2023	109

Page 1